- Location
1
result for "
Alkylating Agents
"-
Mundipharma and Northlake International Have Joined Forces to Develop New Agents
Dec 4, 2012Mundipharma and Northlake International have joined forces to develop structurally new next generation alkylating agents to treat haematological malignancies. Under the $84.5m agreement, Mundipharma and its independent associated ...
Tags: Alkylating Agents, haematological malignancies, alkylation efficiency
